Results 1 to 10 of about 4,259,087 (330)

Next-Generation HDAC Inhibitors: Advancing Zinc-Binding Group Design for Enhanced Cancer Therapy [PDF]

open access: yesCells
Histone deacetylases (HDACs) are pivotal epigenetic regulators that control gene expression, cell proliferation, and differentiation, and their dysregulation is closely associated with the onset and progression of multiple cancers.
Mohammed Hawash
doaj   +3 more sources

Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective [PDF]

open access: yesMetabolites, 2021
Histone deacetylases (HDACs) are epigenetic enzymes that play a central role in gene regulation and are sensitive to the metabolic state of the cell.
Jacob King   +2 more
doaj   +4 more sources

HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases

open access: yesTranslational Oncology, 2022
Histone deacetylases (HDACs) are enzymes that play a key role in the epigenetic regulation of gene expression by remodeling chromatin. Inhibition of HDACs is a prospective therapeutic approach for reversing epigenetic alteration in several diseases.
Geetha Shanmugam   +2 more
doaj   +2 more sources

HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma

open access: yesProtein & Cell, 2020
Immunotherapy has been applied successfully to treat B-cell lymphomas in preclinical models or clinical settings. However, immunotherapy resistance is a major challenge for B-cell lymphoma treatment.
Xiaoguang Wang   +5 more
doaj   +2 more sources

Advancements in Hydrazide-Based HDAC Inhibitors: A Review of Recent Developments and Therapeutic Potential. [PDF]

open access: yesJ Med Chem
Histone deacetylase (HDAC) impairment is strongly related to various cancers as well as neurodegenerative and inflammatory diseases. Considering HDACs’ crucial role as drug targets, over the past decade, the development of HDAC inhibitors (HDACi) has ...
Raucci A, Zwergel C, Valente S, Mai A.
europepmc   +2 more sources

Differential effects of HDAC inhibitors in the Rho I255d mouse model for autosomal dominant retinitis pigmentosa [PDF]

open access: yesCell Death Discovery
Retinitis Pigmentosa (RP) is an inherited neurodegenerative disease which leads to loss of retinal photoreceptors and blindness. Histone deacetylases (HDAC) were previously found to be involved in photoreceptor cell death, and HDAC inhibitors have shown ...
Yu Zhu   +3 more
doaj   +2 more sources

Recent Update of HDAC Inhibitors in Lymphoma

open access: yesFrontiers in Cell and Developmental Biology, 2020
Modulating epigenetic modification has been recognized for over a decade as an effective therapeutic approach to cancer and many studies of histone deacetylase (HDAC), one of the best known epigenetic modulators, have been published.
I-Chung Chen   +2 more
doaj   +2 more sources

Novel dual inhibitors of PARP and HDAC induce intratumoral STING-mediated antitumor immunity in triple-negative breast cancer

open access: yesCell Death and Disease
PARP inhibitors and HDAC inhibitors have been approved for the clinical treatment of malignancies, but acquired resistance of or limited effects on solid tumors with a single agent remain as challenges.
Qingyun Zhu   +13 more
doaj   +2 more sources

Understanding Failure and Improving Treatment Using HDAC Inhibitors for Prostate Cancer

open access: yesBiomedicines, 2020
Novel treatment regimens are required for castration-resistant prostate cancers (CRPCs) that become unresponsive to standard treatments, such as docetaxel and enzalutamide.
Zohaib Rana   +3 more
doaj   +2 more sources

Targeted intervention of tumor microenvironment with HDAC inhibitors and their combination therapy strategies [PDF]

open access: yesEuropean Journal of Medical Research
Histone deacetylation represents a significant epigenetic mechanism that involves the removal of acetyl groups from histones, subsequently influencing gene transcription.
Wanli Zhang   +7 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy